CD34 and Miyoshi myopathy: Taken together, the results demonstrated that a high level of CCL3 activates p38 signalling, resulting in the suppression of transcription factor GATA1 expression and blocking erythroid differentiation of CD34+ HSPCs in the MM bone marrow microenvironment.